当前位置: 首页 » 政策法规 » 国外法规 »§101.72 健康声明:钙、维生素D和骨质疏松症(Health claims: calcium, vitamin D, and osteoporosis)

§101.72 健康声明:钙、维生素D和骨质疏松症(Health claims: calcium, vitamin D, and osteoporosis)

扫描二维码 分享好友和朋友圈
放大字体  缩小字体 2011-08-15 10:08:35  来源:GPO  浏览次数:4117
核心提示:本声明指出钙摄入量不足是导致骨质疏松的因素之一,足够的钙对降低该疾病十分重要。声明中要明确说明骨骼疾病是由多种因素引起的;声明中不能表明或暗示骨质疏松症的发病率在全美人空中是相同的;不得把降低骨质疏松的危险归结为一生中摄入足量的钙;要说明总饮食摄入量大于建议的每日摄入量200%时并无没有更多好处。食品要达到§101.54(b)中规定的高钙含量的要求,钙含量必须是可吸收钙,磷含量不得大于钙含量。
发布单位
FDA
FDA
发布文号 73 FR 56486
发布日期 2008-09-29 生效日期 暂无
有效性状态 废止日期 暂无
备注 本声明指出钙摄入量不足是导致骨质疏松的因素之一,足够的钙对降低该疾病十分重要。声明中要明确说明骨骼疾病是由多种因素引起的;声明中不能表明或暗示骨质疏松症的发病率在全美人空中是相同的;不得把降低骨质疏松的危险归结为一生中摄入足量的钙;要说明总饮食摄入量大于建议的每日摄入量200%时并无没有更多好处。食品要达到§101.54(b)中规定的高钙含量的要求,钙含量必须是可吸收钙,磷含量不得大于钙含量。

      更多关于美国食品标签方面法规,请详见 美国FDA 21 CFR 第101部分食品标签法规汇总

  § 101.72   Health claims: calcium, vitamin D, and osteoporosis.

  (a) Relationship between calcium, vitamin D, and osteoporosis . An inadequate intake of calcium or calcium and vitamin D contributes to low peak bone mass, which has been identified as one of many risk factors in the development of osteoporosis. Peak bone mass is the total quantity of bone present at maturity, and experts believe that it has the greatest bearing on whether a person will be at risk of developing osteoporosis and related bone fractures later in life. Another factor that influences total bone mass and susceptibility to osteoporosis is the rate of bone loss after skeletal maturity. Vitamin D is required for normal absorption of calcium and to prevent the occurrence of high serum parathyroid hormone (PTH) concentration, which stimulates mobilization of calcium from the skeleton and can lower bone mass. Calcium, along with vitamin D and several other nutrients, is required for normal bone mineralization. While vitamin D is required for optimal bone mineralization, it is more effective when calcium intake is adequate. An adequate intake of calcium and vitamin D is thought to exert a positive effect during adolescence and early adulthood in optimizing the amount of bone that is laid down. However, the upper limit of peak bone mass is genetically determined. The mechanism through which adequate intakes of calcium and vitamin D and optimal peak bone mass reduce the risk of osteoporosis is thought to be as follows. All persons lose bone with age. Hence, those with higher bone mass at maturity take longer to reach the critically reduced mass at which bones can fracture easily. The rate of bone loss after skeletal maturity also influences the amount of bone present at old age and can influence an individual's risk of developing osteoporosis. Maintenance of adequate intakes of calcium and vitamin D later in life is thought to be important in reducing the rate of bone loss particularly in the elderly and in women during the first decade following menopause, but a significant protective effect is also seen among men and younger women.

  (b) Significance of calcium or calcium and vitamin D . Adequate calcium intake, or adequate calcium and vitamin D intake, is not the only recognized risk factor in the development of osteoporosis, which is a multifactorial bone disease. Maintenance of adequate calcium and vitamin D intakes throughout life is necessary to achieve optimal peak bone mass and to reduce the risk of osteoporosis in later life. However, vitamin D is most effective in this regard when calcium intake is adequate. Increasing intake of calcium has been shown to have beneficial effects on bone health independent of dietary vitamin D.

  (c) Requirements . (1) All requirements set forth in §101.14 shall be met.

  (2) Specific requirements —(i) Nature of the claim . A health claim associating calcium or, when appropriate, calcium and vitamin D with a reduced risk of osteoporosis may be made on the label or labeling of a food described in paragraphs (c)(2)(ii) and (d)(1) of this section, provided that:

  (A) The claim makes clear the importance of adequate calcium intake, or when appropriate, adequate calcium and vitamin D intake, throughout life, in a healthful diet, are essential to reduce osteoporosis risk. The claim does not imply that adequate calcium intake, or when appropriate, adequate calcium and vitamin D intake, is the only recognized risk factor for the development of osteoporosis;

  (B) The claim does not attribute any degree of reduction in risk of osteoporosis to maintaining an adequate dietary calcium intake, or when appropriate, an adequate dietary calcium and vitamin D intake, throughout life.

  (ii) Nature of the food . (A) The food shall meet or exceed the requirements for a “high” level of calcium as defined in §101.54(b);

  (B) The calcium content of the product shall be assimilable;

  (C) Dietary supplements shall meet the United States Pharmacopeia (USP) standards for disintegration and dissolution applicable to their component calcium salts, except that dietary supplements for which no USP standards exist shall exhibit appropriate assimilability under the conditions of use stated on the product label;

  (D) A food or total daily recommended supplement intake shall not contain more phosphorus than calcium on a weight per weight basis.

  (d) Optional information . (1) The claim may include the term “vitamin D” if the food meets or exceeds the requirements for a “high” level of vitamin D as defined in §101.54(b);

  (2) The claim may include information from paragraphs (a) and (b) of this section.

  (3) The claim may make reference to physical activity.

  (4) The claim may include information on the number of people in the United States, including the number of people in certain subpopulations in the United States, who have osteoporosis or low bone density. The sources of this information must be identified, and it must be current information from the National Center for Health Statistics, the National Institutes of Health, or the National Osteoporosis Foundation.

  (5) The claim may state that the role of adequate calcium intake, or when appropriate, the role of adequate calcium and vitamin D intake, throughout life is linked to reduced risk of osteoporosis through the mechanism of optimizing peak bone mass during adolescence and early adulthood. The phrase “build and maintain good bone health” may be used to convey the concept of optimizing peak bone mass. The claim may also state that adequate intake of calcium, or when appropriate, adequate intake of calcium and vitamin D, is linked to reduced risk of osteoporosis through the mechanism of slowing the rate of bone loss for persons with a family history of the disease, post-menopausal women, and elderly men and women.

  (e) Model health claims . The following model health claims may be used in food labeling to describe the relationship between calcium and osteoporosis:

  Adequate calcium throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis.

  Adequate calcium as part of a healthful diet, along with physical activity, may reduce the risk of osteoporosis in later life.

  (f) Model additional health claims for calcium and vitamin D . The following model health claims may be used in food labeling to describe the relationship between calcium, vitamin D, and osteoporosis:

  Adequate calcium and vitamin D throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis.

  Adequate calcium and vitamin D as part of a healthful diet, along with physical activity, may reduce the risk of osteoporosis in later life.

  [73 FR 56486, Sept. 29, 2008]
 

食品伙伴网提供标准法规解读、舆情监控、合规咨询、申报注册等服务。
电询:0535-2129301
QQ:2891238009
食品标法圈
实时把握食品标法动态
请扫码关注食品标法圈

声明:

① 凡本网所有原始/编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”。
② 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责。
※ 邮箱:law#foodmate.net(发邮件时请将#换成@) QQ:139307733

 
 
[ 政策法规搜索 ]  [ 加入收藏 ]  [ 告诉好友 ]  [ 打印本文 ]  [ 关闭窗口 ]

 

 
 
按分类浏览
国家法规 (11844) 国外法规 (3603)
地方法规 (41828) 法规动态 (12)
法规解读 (2903) 其他法规 (536)
推荐国外法规
点击排行
    按国家或地区浏览

    法规中心  关于我们  广告业务  联系我们  信息服务

    Processed in 0.279 second(s), 10 queries, Memory 4.47 M